For years, researchers have debated the root cause of Alzheimer’s. Two main theories dominate the discussion. The first ...

The New Brunswick, N.J., pharmaceutical giant said posdinemab has shown potential in targeting disease-associated phosphorylated tau in cerebrospinal fluid from treated Alzheimer's patients, and in ...

Discover a groundbreaking study that may help detect Alzheimer's in its early stages. Learn about the link between blood ...